(Q61980871)

English

Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)

clinical trial

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

clinical trial

0 references

title

Onset of Action of Advair HFA 115/21 in Comparison to Symbicort pMDI 160/4.5 Measured by Impulse Oscillometry, IOS. (English)

0 references

country

United States of America

0 references

main subject

Impulse oscillometry in COPD: Identification of measurements related to airway obstruction, airway conductance and lung volumes

0 references

start time

September 2008

0 references

end time

September 2009

0 references

number of participants

30

0 references

research intervention

formoterol fumarate

0 references

clinical trial phase

phase IV clinical trial

0 references

research subject recruitment status

unknown

0 references

minimum age

12 year

0 references

maximum age

45 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00867737

0 references

(Q61980871)

Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)